Bavituximab, referred to as TRWH-783, represents a innovative treatment strategy targeting phosphatidylserine (PS). PS is normally a inside lipid present inside cell membranes; however, it's commonly displayed on the https://bookmark-template.com/story28492001/bavituximab-a-novel-method-to-tumor-therapy